CLSA Downgrades Emerson (EMR) to Sell
Tweet
Share
E-mail
Get Alerts EMR Hot Sheet
Price: $151.72 --0%
Rating Summary:
26 Buy, 20 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 30
Rating Summary:
26 Buy, 20 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 30
Join SI Premium – FREE
CLSA downgraded Emerson (NYSE: EMR) from Underperform to Sell.
For an analyst ratings summary and ratings history on Emerson click here. For more ratings news on Emerson click here.
Shares of Emerson closed at $53.03 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- William Blair Downgrades Endava PLC (ADR) (DAVA) to Underperform
- JPMorgan Downgrades Guangdong Marubi Biotechnology Co Ltd (603983:CH) to Underweight
- RBC Capital Downgrades LVMH (MC:FP) (LVMUY) to Sector Perform
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
